# Mesenteric Artery Disease: Acute and Chronic Ischemia

## Overview

Mesenteric ischemia occurs when the blood flow to the intestines is insufficient to meet metabolic demands. Acute mesenteric ischemia (AMI) is a surgical emergency characterized by high mortality rates ranging from 50 to 80 percent. In contrast, chronic mesenteric ischemia (CMI) develops more gradually and typically presents with postprandial abdominal pain and weight loss. The mesenteric circulation is supported by extensive collateral networks, which usually protect against ischemia; therefore, symptoms generally arise only when two or more of the three major mesenteric vessels are occluded.

## Mesenteric Vascular Anatomy

The mesenteric arterial supply consists of three main vessels. The celiac artery (CA) supplies the stomach, liver, spleen, and proximal duodenum. The superior mesenteric artery (SMA) supplies the small bowel, right colon, and proximal transverse colon and is considered the most critical vessel for intestinal perfusion. The inferior mesenteric artery (IMA) supplies the left colon, sigmoid colon, and proximal rectum. Several key collateral pathways connect these vessels, including the pancreaticoduodenal arcades linking the celiac artery and SMA, the Arc of Riolan (also known as the meandering mesenteric artery) connecting the SMA and IMA, and the marginal artery of Drummond running along the colon. Additionally, the internal iliac arteries provide collateral flow to the rectum and pelvic region, supporting the IMA territory.

## Acute Mesenteric Ischemia (AMI)

### Etiologies

Acute mesenteric ischemia arises from several distinct causes. The most common cause, accounting for 40-50% of cases, is embolism to the SMA. These emboli typically originate from cardiac sources such as atrial fibrillation, left ventricular thrombus, or valvular disease. Emboli usually lodge 3 to 8 cm distal to the SMA origin, beyond the middle colic artery branch, sparing the proximal jejunum supplied by proximal branches. SMA thrombosis, responsible for 20-30% of cases, occurs due to thrombosis superimposed on pre-existing atherosclerotic stenosis at the SMA origin. This often follows symptoms of chronic mesenteric ischemia and occludes the vessel at its origin, affecting the entire SMA distribution. Non-occlusive mesenteric ischemia (NOMI), comprising about 20% of cases, results from splanchnic vasoconstriction in low-flow states such as cardiogenic shock, sepsis, vasopressor use, hemodialysis, or cardiac surgery. NOMI causes diffuse, patchy ischemia without mechanical obstruction. Mesenteric venous thrombosis (MVT), accounting for 5-10% of cases, involves thrombosis of the superior mesenteric vein and is associated with hypercoagulable states, cirrhosis, portal hypertension, malignancy, and pancreatitis. MVT typically has an insidious onset over several days and leads to segmental bowel wall edema and hemorrhagic infarction.

| Etiology | Frequency | Mechanism | Typical Location | Onset | Key Features |
|----------|-----------|-----------|-----------------|-------|--------------|
| SMA embolism | 40–50% | Cardiac source (AF, LV thrombus) | 3–8 cm distal to SMA origin (beyond middle colic) | Sudden | Spares proximal jejunum; Fogarty embolectomy |
| SMA thrombosis | 20–30% | Thrombosis on pre-existing atherosclerosis | SMA origin | Acute on chronic (prior CMI symptoms) | Entire SMA distribution affected; bypass often needed |
| NOMI | ~20% | Splanchnic vasoconstriction (low-flow state) | Diffuse, patchy | Variable | No mechanical obstruction; treat underlying cause; papaverine infusion |
| Mesenteric venous thrombosis | 5–10% | Hypercoagulable state, portal HTN, malignancy | SMV | Insidious (days) | Bowel wall edema; anticoagulation is primary treatment |

<image>Diagram of mesenteric arterial anatomy showing the celiac artery, SMA, and IMA with their major branches, collateral pathways (pancreaticoduodenal arcades, Arc of Riolan, marginal artery of Drummond), and the typical sites of embolic lodgment versus thrombotic occlusion in the SMA</image>

### Clinical Presentation of AMI

The classic presentation of AMI is severe, diffuse abdominal pain that is often described as "pain out of proportion to physical examination," although this sign is not always present. The pain usually begins in the periumbilical region and is accompanied by nausea, vomiting, and diarrhea, which may be bloody. Early in the course, rapid bowel emptying or "gut emptying" can occur. As ischemia progresses to bowel necrosis, abdominal distension and signs of peritonitis develop. Late complications include sepsis and multiorgan failure. In cases of mesenteric venous thrombosis, the onset is more gradual over days, with symptoms of abdominal pain, bloating, and diarrhea.

### Diagnosis

A high index of clinical suspicion is critical for diagnosing AMI, as delays contribute significantly to its high mortality. Computed tomography angiography (CTA) is the imaging modality of choice. During the arterial phase, CTA can reveal SMA occlusion, distinguishing embolic from thrombotic causes by identifying filling defects. The venous phase is useful for detecting mesenteric venous thrombosis, bowel wall enhancement abnormalities, and pneumatosis intestinalis. Additional findings on imaging may include bowel wall thickening or thinning, mesenteric stranding, portal venous gas, free fluid, and pneumatosis. Laboratory studies often show leukocytosis, elevated lactate (which is a late and nonspecific marker), metabolic acidosis, elevated D-dimer, and increased lactate dehydrogenase (LDH). Importantly, a normal lactate level does not exclude AMI. Catheter angiography serves both diagnostic and therapeutic roles, particularly for embolism, allowing for intervention during the procedure. Plain abdominal radiographs may show late findings such as dilated bowel loops, thumbprinting, pneumatosis, and portal venous gas but are not sensitive early in the disease.

### Management of AMI

Initial management focuses on resuscitation with intravenous fluids, broad-spectrum antibiotics, and anticoagulation using intravenous heparin. Correction of electrolyte imbalances and acidosis is essential, along with nasogastric tube decompression. Vasoconstrictors should be avoided if possible to prevent worsening ischemia.

For SMA embolism, the traditional treatment is surgical embolectomy via laparotomy, involving exposure of the SMA at the root of the mesentery, transverse arteriotomy, and Fogarty catheter thromboembolectomy. If there is no peritonitis and the bowel remains viable, catheter-directed thrombolysis or aspiration thrombectomy may be considered. A hybrid approach combining endovascular revascularization with laparoscopic or open bowel assessment is increasingly used. After revascularization, bowel viability must be carefully assessed. A planned second-look laparotomy at 24 to 48 hours is critical to reassess bowel viability, preventing premature resection of potentially recoverable bowel and identifying delayed necrosis.

In SMA thrombosis, open bypass procedures such as aorto-SMA or iliac-SMA bypass using reversed saphenous vein or prosthetic grafts are performed. Retrograde SMA bypass from the right common iliac artery to the SMA can avoid suprarenal aortic clamping. Endovascular treatment with SMA angioplasty and stenting is increasingly used as a first-line option in patients without peritonitis, but simultaneous bowel assessment remains essential.

Management of NOMI centers on treating the underlying cause by improving cardiac output and reducing vasopressor use. Catheter-directed vasodilator infusion, using agents like papaverine or prostaglandin E1 via an SMA catheter, can improve splanchnic blood flow. Surgery is reserved for cases with bowel necrosis. Early diagnosis often allows for non-operative management.

Mesenteric venous thrombosis is primarily treated with anticoagulation starting with intravenous heparin, followed by long-term anticoagulation, often lifelong in patients with hypercoagulable conditions. Surgery is indicated only for peritonitis or bowel necrosis requiring resection. Catheter-directed thrombolysis may be considered for extensive superior mesenteric vein thrombosis without peritonitis. A second-look laparotomy is also recommended in these cases.

<image>CT angiography images showing (A) acute SMA embolism with filling defect in the proximal SMA and non-enhancing small bowel loops, and (B) mesenteric venous thrombosis with SMV thrombus, bowel wall thickening, and mesenteric edema</image>

## Chronic Mesenteric Ischemia (CMI)

### Pathophysiology

Chronic mesenteric ischemia results from progressive atherosclerotic stenosis or occlusion of the mesenteric arteries. Symptoms develop when blood flow is insufficient to meet the increased postprandial demand. Because of collateral circulation, clinical manifestations usually require involvement of at least two of the three major vessels: the celiac artery, superior mesenteric artery, and inferior mesenteric artery. The condition most commonly affects elderly women who are heavy smokers.

### Clinical Presentation

The classic triad of CMI includes postprandial abdominal pain occurring 15 to 30 minutes after eating, food aversion or sitophobia due to fear of pain, and significant weight loss often amounting to 10 to 15 kilograms. However, this triad is present in only about 30% of patients. Other symptoms may include nausea, diarrhea, or constipation. CMI is frequently misdiagnosed, leading to extensive gastrointestinal workups before vascular evaluation is considered. On physical examination, patients often appear thin and malnourished, and an epigastric bruit is present in approximately half of cases.

### Diagnosis

Diagnosis relies on imaging studies such as computed tomography angiography (CTA) or magnetic resonance angiography (MRA), which reveal multivessel mesenteric stenosis or occlusion, most commonly involving the SMA and celiac artery. Duplex ultrasound can detect elevated peak systolic velocities (PSV) in these vessels, with a PSV greater than 200 cm/s in the celiac artery and greater than 275 cm/s in the SMA indicating significant stenosis (≥70%). Additionally, a fasting end-diastolic velocity above 45 cm/s in the SMA supports the diagnosis. Catheter angiography remains the gold standard, particularly lateral aortography, because the mesenteric arteries arise anteriorly and are poorly visualized on anteroposterior views.

### Treatment of CMI

Open surgical revascularization options include antegrade aortomesenteric bypass, which connects the supraceliac aorta to the SMA, with or without the celiac artery, using prosthetic or vein grafts. This approach is the most durable but requires suprarenal or supraceliac aortic clamping. Retrograde bypass from the infrarenal aorta or iliac artery to the SMA avoids supraceliac clamping but requires careful graft placement to prevent kinking. Mesenteric endarterectomy, involving trapdoor endarterectomy of the celiac and SMA origins, is another option. Open surgery offers excellent long-term patency rates of 85 to 95 percent at five years, with perioperative mortality ranging from 3 to 8 percent.

Endovascular revascularization typically involves percutaneous SMA angioplasty and stenting via femoral or brachial access. This approach has a technical success rate exceeding 95%, with advantages including lower perioperative morbidity and faster recovery. However, it has lower long-term patency (60-80% at 3 to 5 years) and higher rates of restenosis and reintervention. Recurrent symptoms occur in 20 to 40 percent of patients at three years. Covered stents may provide improved patency compared to bare-metal stents in the mesenteric position.

The choice between endovascular and open repair remains controversial due to the lack of randomized trials. Retrospective data suggest that open surgery offers superior long-term patency and symptom-free survival, while endovascular treatment has lower perioperative morbidity and mortality. Current trends favor an endovascular-first approach in many centers, reserving open repair for failures, younger or fitter patients, or those with complex anatomy. The Society for Vascular Surgery (SVS) guidelines recommend an individualized approach based on anatomy, patient fitness, and expected durability.

## Clinical Pearls

In acute mesenteric ischemia, maintaining a high clinical suspicion is paramount, as early recognition significantly reduces mortality. Although "pain out of proportion to the physical examination" is the classic finding, it is not universally present. Performing a second-look laparotomy 24 to 48 hours after initial surgery is a critical step that should never be omitted, as it helps identify delayed bowel necrosis and prevents unnecessary resections. Lactate is a late marker of ischemia, so a normal lactate level does not exclude the diagnosis. In chronic mesenteric ischemia, lateral aortography is essential because the mesenteric arteries arise anteriorly and are foreshortened on standard anteroposterior views. Revascularization should aim to restore flow to both the SMA and celiac artery when possible to reduce recurrence. While endovascular treatment of CMI achieves high early success rates, it is associated with significant restenosis, necessitating close postoperative surveillance.

## References
- Bjorck M, et al. ESVS 2017 Clinical Practice Guidelines on Mesenteric Ischaemia. Eur J Vasc Endovasc Surg. 2017;53(4):460-510.
- Schermerhorn ML, et al. Mesenteric revascularization: management and outcomes in the United States. J Vasc Surg. 2009;50(2):341-348.
- Park WM, et al. Contemporary management of acute mesenteric ischemia. J Vasc Surg. 2002;36(2):205-210.
- Oderich GS, et al. Comparison of endovascular and open treatment for chronic mesenteric ischemia. J Vasc Surg. 2009;49(6):1472-1479.
- Acosta S. Mesenteric ischemia. Curr Opin Crit Care. 2015;21(2):171-178.